The released QUE can reduce the high expression of PD-L1 on the surface of tumor cells, thus promoting the infiltration of cytotoxic T lymphocytes into the TME and enhancing the effect of tumor immunotherapy (154). This evidence concerns the gene CD274 and neoplasm.